DIAGNOS Inc. (DGNOF)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 170.15 Thousand CAD | -61.22% |
| 2023 | 438.83 Thousand CAD | 64.31% |
| 2022 | 267.07 Thousand CAD | -19.44% |
| 2021 | 331.51 Thousand CAD | 1.55% |
| 2020 | 326.46 Thousand CAD | 0.0% |
| 2019 | 326.46 Thousand CAD | -79.76% |
| 2018 | 1.61 Million CAD | -32.52% |
| 2017 | 2.39 Million CAD | 143.51% |
| 2016 | 981.48 Thousand CAD | 73.97% |
| 2015 | 564.17 Thousand CAD | -79.14% |
| 2014 | 2.7 Million CAD | 79.27% |
| 2013 | 1.5 Million CAD | 13.64% |
| 2012 | 1.32 Million CAD | 23.57% |
| 2011 | 1.07 Million CAD | 200.08% |
| 2010 | 358.07 Thousand CAD | -81.01% |
| 2009 | 1.88 Million CAD | 1.22% |
| 2008 | 1.86 Million CAD | 140.19% |
| 2007 | 775.72 Thousand CAD | 9.38% |
| 2006 | 709.18 Thousand CAD | 534.64% |
| 2005 | 111.74 Thousand CAD | -71.18% |
| 2004 | 387.72 Thousand CAD | 201.45% |
| 2003 | 128.61 Thousand CAD | 1737.41% |
| 2002 | 7000.00 CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 41.99 Thousand CAD | -19.44% |
| 2024 FY | 170.15 Thousand CAD | -61.22% |
| 2024 Q1 | 149.01 Thousand CAD | -2.03% |
| 2024 Q2 | 146.53 Thousand CAD | -1.66% |
| 2024 Q3 | 52.13 Thousand CAD | -64.42% |
| 2023 Q4 | 152.1 Thousand CAD | 24.76% |
| 2023 Q3 | 121.91 Thousand CAD | -16.8% |
| 2023 Q2 | 146.53 Thousand CAD | -1.66% |
| 2023 Q1 | 149.01 Thousand CAD | -2.03% |
| 2023 FY | 438.83 Thousand CAD | 64.31% |
| 2022 Q3 | 129.83 Thousand CAD | 60.42% |
| 2022 FY | 267.07 Thousand CAD | -19.44% |
| 2022 Q2 | 80.93 Thousand CAD | 6.55% |
| 2022 Q1 | 75.96 Thousand CAD | 23.08% |
| 2022 Q4 | 152.1 Thousand CAD | 17.15% |
| 2021 Q3 | 77.87 Thousand CAD | -2.39% |
| 2021 Q2 | 79.78 Thousand CAD | 67.3% |
| 2021 FY | 331.51 Thousand CAD | 1.55% |
| 2021 Q1 | 47.69 Thousand CAD | -38.6% |
| 2021 Q4 | 61.71 Thousand CAD | -20.75% |
| 2020 Q4 | 77.67 Thousand CAD | -14.03% |
| 2020 FY | 326.46 Thousand CAD | 0.0% |
| 2020 Q2 | 82.05 Thousand CAD | 0.77% |
| 2020 Q3 | 90.35 Thousand CAD | 10.11% |
| 2020 Q1 | 81.43 Thousand CAD | -10.66% |
| 2019 FY | 326.46 Thousand CAD | -79.76% |
| 2019 Q3 | 94.51 Thousand CAD | 98.19% |
| 2019 Q1 | 93.12 Thousand CAD | 39.84% |
| 2019 Q2 | 47.68 Thousand CAD | -48.79% |
| 2019 Q4 | 91.14 Thousand CAD | -3.56% |
| 2018 Q2 | 269.4 Thousand CAD | -20.62% |
| 2018 Q4 | 66.59 Thousand CAD | -92.9% |
| 2018 FY | 1.61 Million CAD | -32.52% |
| 2018 Q3 | 937.42 Thousand CAD | 247.96% |
| 2018 Q1 | 339.39 Thousand CAD | -5.19% |
| 2017 Q4 | 357.97 Thousand CAD | -74.49% |
| 2017 Q1 | 265.54 Thousand CAD | 10.23% |
| 2017 Q2 | 363.26 Thousand CAD | 36.8% |
| 2017 FY | 2.39 Million CAD | 143.51% |
| 2017 Q3 | 1.4 Million CAD | 286.3% |
| 2016 Q4 | 240.89 Thousand CAD | -33.84% |
| 2016 FY | 981.48 Thousand CAD | 73.97% |
| 2016 Q3 | 364.08 Thousand CAD | 61.18% |
| 2016 Q2 | 225.88 Thousand CAD | 49.98% |
| 2016 Q1 | 150.61 Thousand CAD | 18.26% |
| 2015 Q2 | 116.17 Thousand CAD | 3.58% |
| 2015 FY | 564.17 Thousand CAD | -79.14% |
| 2015 Q1 | 112.16 Thousand CAD | -23.75% |
| 2015 Q4 | 127.36 Thousand CAD | -38.91% |
| 2015 Q3 | 208.47 Thousand CAD | 79.45% |
| 2014 Q2 | 1.51 Million CAD | 159.15% |
| 2014 FY | 2.7 Million CAD | 79.27% |
| 2014 Q4 | 147.1 Thousand CAD | -68.05% |
| 2014 Q3 | 460.45 Thousand CAD | -69.58% |
| 2014 Q1 | 584 Thousand CAD | 3.16% |
| 2013 FY | 1.5 Million CAD | 13.64% |
| 2013 Q4 | 566.09 Thousand CAD | 138.71% |
| 2013 Q3 | 237.14 Thousand CAD | 10.84% |
| 2013 Q2 | 213.96 Thousand CAD | -56.49% |
| 2013 Q1 | 491.7 Thousand CAD | -8.56% |
| 2012 Q4 | 537.73 Thousand CAD | 14.02% |
| 2012 Q2 | 186.86 Thousand CAD | 42.0% |
| 2012 Q3 | 471.62 Thousand CAD | 152.39% |
| 2012 FY | 1.32 Million CAD | 23.57% |
| 2012 Q1 | 131.59 Thousand CAD | -70.16% |
| 2011 Q4 | 441 Thousand CAD | 96.64% |
| 2011 Q3 | 224.27 Thousand CAD | -18.13% |
| 2011 Q2 | 273.93 Thousand CAD | 102.47% |
| 2011 Q1 | 135.3 Thousand CAD | -4.17% |
| 2011 FY | 1.07 Million CAD | 200.08% |
| 2010 Q1 | 52.87 Thousand CAD | 162.48% |
| 2010 FY | 358.07 Thousand CAD | -81.01% |
| 2010 Q3 | 142.49 Thousand CAD | 562.55% |
| 2010 Q4 | 141.19 Thousand CAD | -0.91% |
| 2010 Q2 | 21.5 Thousand CAD | -59.33% |
| 2009 Q1 | 510.22 Thousand CAD | 1.98% |
| 2009 FY | 1.88 Million CAD | 1.22% |
| 2009 Q4 | -84.63 Thousand CAD | -119.3% |
| 2009 Q3 | 438.5 Thousand CAD | -57.09% |
| 2009 Q2 | 1.02 Million CAD | 100.28% |
| 2008 Q2 | 336.71 Thousand CAD | 74.25% |
| 2008 Q1 | 193.23 Thousand CAD | -3.38% |
| 2008 FY | 1.86 Million CAD | 140.19% |
| 2008 Q4 | 500.34 Thousand CAD | -39.93% |
| 2008 Q3 | 832.89 Thousand CAD | 147.36% |
| 2007 Q1 | 96.53 Thousand CAD | -63.71% |
| 2007 Q2 | 231.68 Thousand CAD | 140.0% |
| 2007 Q3 | 97.5 Thousand CAD | -57.92% |
| 2007 Q4 | 200 Thousand CAD | 105.13% |
| 2007 FY | 775.72 Thousand CAD | 9.38% |
| 2006 Q1 | 180.08 Thousand CAD | 504.71% |
| 2006 Q3 | 90.41 Thousand CAD | -47.63% |
| 2006 Q4 | 266.01 Thousand CAD | 194.21% |
| 2006 Q2 | 172.66 Thousand CAD | -4.12% |
| 2006 FY | 709.18 Thousand CAD | 534.64% |
| 2005 Q1 | 103.96 Thousand CAD | -31.01% |
| 2005 Q4 | -44.49 Thousand CAD | -193.14% |
| 2005 Q3 | 47.77 Thousand CAD | 960.72% |
| 2005 Q2 | 4504.00 CAD | -95.67% |
| 2005 FY | 111.74 Thousand CAD | -71.18% |
| 2004 Q4 | 150.68 Thousand CAD | 356.56% |
| 2004 FY | 387.72 Thousand CAD | 201.45% |
| 2004 Q3 | 33 Thousand CAD | -83.88% |
| 2004 Q1 | - CAD | -100.0% |
| 2004 Q2 | 204.71 Thousand CAD | 0.0% |
| 2003 Q3 | 93.89 Thousand CAD | -14.74% |
| 2003 Q4 | 23.58 Thousand CAD | -74.88% |
| 2003 FY | 128.61 Thousand CAD | 1737.41% |
| 2003 Q2 | 110.12 Thousand CAD | 1483.19% |
| 2003 Q1 | 6956.00 CAD | 0.0% |
| 2002 FY | 7000.00 CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Achiko AG | 62.5 Thousand USD | -172.222% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 8.52 Million USD | 98.004% |
| Cannabis Sativa, Inc. | 1.17 Million USD | 85.504% |
| CompuMed, Inc. | 5.83 Million USD | 97.085% |
| CompuGroup Medical SE & Co. KGaA | 1.31 Billion USD | 99.987% |
| Cogstate Limited | 43.42 Million USD | 99.608% |
| CareView Communications, Inc. | 9.68 Million USD | 98.243% |
| Craneware plc | 189.26 Million USD | 99.91% |
| Caduceus Software Systems Corp. | 6.58 Million USD | 97.417% |
| Certive Solutions Inc. | 1.27 Million USD | 86.606% |
| Drug Free Solution, Inc. | 805.00 USD | -21037.64% |
| DATATRAK International, Inc. | 6.18 Million USD | 97.249% |
| Strainsforpains, Inc. | 84.11 Thousand USD | -102.29% |
| Healixa Inc. | 598.88 Thousand USD | 71.588% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 16.45 Million USD | 98.966% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 322 Thousand USD | 47.156% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | - USD | -Infinity% |
| iCoreConnect Inc. | 8.15 Million USD | 97.913% |
| IQ-AI Limited | 775.75 Thousand USD | 78.065% |
| Cannabiz Mobile, Inc. | - USD | -Infinity% |
| Mednow Inc. | 12.99 Million USD | 98.691% |
| Galileo Life Sciences, Inc. | - USD | -Infinity% |
| MediXall Group, Inc. | 59.26 Thousand USD | -187.099% |
| Mitesco, Inc. | - USD | -Infinity% |
| MobileSmith, Inc. | 1.57 Million USD | 89.182% |
| NantHealth, Inc. | 67 Million USD | 99.746% |
| Net Medical Xpress Solutions, Inc. | 597 Thousand USD | 71.498% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 324.86 Thousand USD | 47.623% |
| Patient Access Solutions, Inc. | 212.73 Thousand USD | 20.014% |
| Pharma-Bio Serv, Inc. | 16.97 Million USD | 98.998% |
| PPJ Healthcare Enterprises, Inc. | 711.03 Thousand USD | 76.069% |
| Medical Cannabis Payment Solutions, Inc. | - USD | -Infinity% |
| Renalytix Plc | 2.28 Million USD | 92.566% |
| Revium Recovery Inc. | - USD | -Infinity% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 1.46 Million USD | 88.38% |
| Vaso Corporation | 81.02 Million USD | 99.79% |
| Vynleads, Inc. | - USD | -Infinity% |